Developing a new drug to treat infants hospitalised with RSV infection

• Research type

  Research Study

• Full title

  A Randomized, Double-blind, Placebo-controlled, 2-Part Study of Orally Administered ALS-008176 to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Dosing and Multiple Ascending Dosing in Infants Hospitalized with Respiratory Syncytial Virus (RSV) Infection

• IRAS ID

  143136

• Contact name

  Adam Finn

• Contact email

  adam.finn@bristol.ac.uk

• Sponsor organisation

  ALIOS BioPharma

• Eudract number

  2013-005104-33

• ISRCTN Number

  n/a

• Clinicaltrials.gov Identifier

  n/a

• REC name

  West Midlands - Edgbaston Research Ethics Committee

• REC reference

  14/WM/0013

• Date of REC Opinion

  24 Jan 2014

• REC opinion

  Further Information Favourable Opinion